US Patent Issued to GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT on Jan. 13 for "Cytotoxicity targeting chimeras for CCR2-expressing cells" (Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,393, issued on Jan. 13, was assigned to GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Ltd. (Brentford, Great Britain).

"Cytotoxicity targeting chimeras for CCR2-expressing cells" was invented by Peiling Chen (Collegeville, Pa.), Jason W. Dodson (Collegeville, Pa.), Beth A. Knapp-Reed (Collegeville, Pa.), Craig Leach (Collegeville, Pa.), Yuehu Li (Collegeville, Pa.), Joseph Paul Marino Jr. (Collegeville, Pa.), Matthew Robert Sender (Collegeville, Pa.), Brandon Turunen (Collegeville, Pa.), Guosen Ye (Collegeville, Pa.) and Cunyu Zhang (Collegeville, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to heterobifuncti...